Zachary Grinspan
Neurology with Special Qualifications in Child Neurology New York, NY Medical Doctor
NPI 1033377338 CMS profile 876515
505 E 70Th St Fl 3, New York, NY 10021
General payments
$2,140
Research payments
$0
Ownership & investment interest
$0
Research they led as principal investigator
$232,268
Through program year 2025, Zachary Grinspan of New York, NY is reported in the CMS Open Payments database as having received $2,140 across 3 general payments and $0 in research payments paid to them. Separately, studies naming them as principal investigator received $232,268 in research payments, paid to institutions rather than to them.
No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.
General payments for this record sit in the 63rd percentile of Neurology with Special Qualifications in Child Neurology profiles with reported payments. Percentile describes the distribution, not the conduct.
By program year
1 row| Year | Kind | Relative to this record's peak year | Amount | Records |
|---|---|---|---|---|
| 2025 | General | $2,140 | 3 |
Beside peers
- Zachary Grinspan
- Neurology with Special Qualifications in Child Neurology median
- Middle half of Neurology with Special Qualifications in Child Neurology
- National median
In program year 2025, general payments to Zachary Grinspan were reported at $2,140. Among 1,228 Neurology with Special Qualifications in Child Neurology profiles paid that year, the median was $276 and the middle half received between $87 and $1,522.
Show as a table
| Year | Zachary Grinspan | Neurology with Special Qualifications in Child Neurology median | Middle half | National median |
|---|---|---|---|---|
| 2019 | $0 | $262 | $68–$1,313 | $163 |
| 2020 | $0 | $188 | $46–$1,222 | $114 |
| 2021 | $0 | $183 | $45–$1,356 | $132 |
| 2022 | $0 | $229 | $72–$1,177 | $149 |
| 2023 | $0 | $269 | $93–$1,195 | $160 |
| 2024 | $0 | $300 | $98–$1,428 | $164 |
| 2025 | $2,140 | $276 | $87–$1,522 | $169 |
Breakdown
Records
3 reportedEvery payment, record by record
Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.
Other Neurology with Special Qualifications in Child Neurology in New York
Claudia Chiriboga
Neurology with Special Qualifications in Child Neurology · New York, NY
Eric Segal
Neurology with Special Qualifications in Child Neurology · N White Plains, NY
Kaleb Yohay
Neurology with Special Qualifications in Child Neurology · New York, NY
Heather Lau
Neurology with Special Qualifications in Child Neurology · New York, NY
Louis Manganas
Neurology with Special Qualifications in Child Neurology · East Setauket, NY
Darryl Devivo
Neurology with Special Qualifications in Child Neurology · New York, NY
Related records
Neurology with Special Qualifications in Child Neurology in New York
Practitioners in the same specialty and state, ranked by reported value.
All Neurology with Special Qualifications in Child Neurology
Everyone recorded under this specialty, nationwide.
Doctors in New York
Every practitioner in the state with a reported payment.
How to read this page
What each amount means, and what it does not mean.
What this means
U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.
An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.
Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.